Collectively, these findings indicate that host IP6K1 deletion leads to failure of dendritic cell migration into the tumor microenvironment, thereby limiting activation and infiltration of anti-tumor CD8+ T cells, subsequently aiding tumor growth in IP6K1 KO mice. Here, IP6K1 is linked to neoplasm.